There were 1,850 press releases posted in the last 24 hours and 403,476 in the last 365 days.

Rising Biopharmaceutical Demand Propels The Fetal Bovine Serum Market Growth

Fetal Bovine Serum Market Report 2021: COVID-19 Growth And Change

Fetal Bovine Serum Global Market Report 2021: COVID-19 Growth And Change

The Business Research Company’s Fetal Bovine Serum Global Market Report 2021: COVID-19 Growth And Change

LONDON, GREATER LONDON, UK, June 3, 2021 /EINPresswire.com/ -- The increasing demand for biopharmaceuticals is expected to drive the growth of the fetal bovine serum market in the forecast period. A biopharmaceutical is a medicinal product that is derived from biological sources such as animals, humans, and microorganisms using biotechnology. Fetal bovine serum (FBS) is the most widely used substitute for animal cell culture media. Pharmaceutical firms, diagnostic laboratories, and researchers rely heavily on FBS for much of their cell culture requirements in biologics research. The global biologics market is expected to increase from $253.4 billion in 2020 to $420.5 billion by 2025. Therefore, the rising demand for biopharmaceuticals propels the growth of the fetal bovine serum market.

The fetal bovine serum market consists of sales of fetal bovine serum by entities (organizations, sole traders, and partnerships) that are engaged in manufacturing fetal bovine serum and related services. Fetal bovine serum refers to the liquid fraction of clotted blood from fetal calves, with reduced cells, fibrin, and clotting factors. It has high concentration of nutritional and macromolecular factors essential for cell growth and is a critical raw material for animal care, biotechnology, drug development, diagnostics, and other fields of research.

Read More On The Global Fetal Bovine Serum Market Report:
https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report

The global fetal bovine serum market size is expected to grow from $855.80 million in 2020 to $946.25 million in 2021 at a compound annual growth rate (CAGR) of 10.6%. The growth in mainly due to increase in R&D towards development of novel biopharmaceuticals. The fetal bovine serum market is expected to reach $1,175.36 million in 2025 at a CAGR of 5.6%.

North America was the largest region in the fetal bovine serum (FBS) market in 2020. Asia Pacific recorded the fastest growth during the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Major players in the fetal bovine serum industry are Sartorius AG, GE Healthcare, PAN- Biotech, Thermo Fisher Scientific Inc., Biowest, Bio-Techne, Rocky Mountain Biologicals Inc., Merck KGaA, TCS Biosciences Ltd, Bovogen Biologicals Pty Ltd, Tissue Culture Biologicals, Atlanta Biologicals Inc., Atlas Biologicals, Acess Biologicals, Animal Technologies Inc, Nucleus Biologics, Corning Incorporated, J R Scientific Inc., Cytiva, Axil Scientific Pte Ltd, and Moregate Biotech.

The global fetal bovine serum market research report is segmented by product into charcoal stripped, chromatographic, dialyzed fetal bovine serum, exosome depleted, stem cell, others, by application into drug discovery, cell culture media, in vitro fertilization, human and animal vaccine production, diagnostics, others, and by end-user into research and academic institutes, biotechnology and pharmaceutical industry, others.

Fetal Bovine Serum Global Market Report 2021: COVID-19 Growth And Change is one of a series of new reports from The Business Research Company that provides fetal bovine serum market overview, forecast fetal bovine serum market size and growth for the whole market, fetal bovine serum market segments, and geographies, fetal bovine serum market trends, fetal bovine serum market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Fetal Bovine Serum Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Biotechnology Services Market - By Service (Health Education and Research, Food Biotechnology Services, Donor Recruitment, Tissue Collection, Cell Processing and Isolation, Research and Development), By Industry (Clinical Research Organizations (CROs), Contract Manufacturers Organizations (CMOs), Contract Research and Manufacturing Services (CRAMS)), By Area Of Application (Pharmaceuticals, Biotechnological, Academic, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/biotechnology-services-market-

Pharmaceuticals Global Market Report 2021: COVID-19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-global-market-report

Scientific Research And Development Services Global Market Report 2021: COVID-19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/scientific-research-and-development-services-global-market-report-2020-30-covid-19-impact-and-recovery

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn